Norges Bank Theravance Biopharma, Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

44 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$8.38 - $10.44 $4.57 Million - $5.69 Million	-545,427 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$10.16 - $11.92 $4.59 Million - $5.38 Million	451,338 New	451,338 $4.67 Million
Q2 2023 Aug 14, 2023	SELL	$10.16 - $11.92 $5.54 Million - $6.5 Million	-545,427 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$9.87 - $11.44 $4.45 Million - $5.16 Million	451,338 New	451,338 $4.9 Million
Q4 2022 Feb 14, 2023	BUY	$9.65 - $11.34 $5.26 Million - $6.19 Million	545,427 New	545,427 $6.12 Million
Q3 2022 Nov 13, 2023	BUY	$8.39 - $10.22 $4.58 Million - $5.57 Million	545,427 New	545,427 $5.53 Million
Q2 2022 Aug 14, 2023	BUY	$8.41 - $10.34 $4.59 Million - $5.64 Million	545,427 New	545,427 $4.94 Million
Q1 2022 May 12, 2023	SELL	$8.33 - $12.96 $102,733 - $159,835	-12,333 Reduced 2.26%	533,094 $5.1 Million
Q1 2022 May 09, 2022	SELL	$8.33 - $12.96 $4.44 Million - $6.91 Million	-533,094 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$7.42 - $11.05 $3.96 Million - $5.89 Million	533,094 New	533,094 $5.89 Million
Q3 2021 Nov 14, 2022	BUY	$6.77 - $14.41 $1.64 Million - $3.49 Million	242,494 New	242,494 $1.79 Million
Q3 2021 Nov 05, 2021	SELL	$6.77 - $14.41 $2.78 Million - $5.92 Million	-410,611 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$14.52 - $22.46 $5.96 Million - $9.22 Million	410,611 New	410,611 $5.96 Million
Q2 2021 Aug 10, 2021	SELL	$14.52 - $22.46 $7.41 Million - $11.5 Million	-510,011 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$16.57 - $21.08 $8.45 Million - $10.8 Million	510,011 New	510,011 $10.4 Million
Q1 2021 May 07, 2021	SELL	$16.57 - $21.08 $10.9 Million - $13.9 Million	-657,681 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$14.89 - $20.16 $9.79 Million - $13.3 Million	657,681 New	657,681 $11.7 Million
Q4 2020 Feb 10, 2021	SELL	$14.89 - $20.16 $15 Million - $20.4 Million	-1,009,823 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$14.79 - $22.49 $14.9 Million - $22.7 Million	1,009,823 New	1,009,823 $14.9 Million
Q3 2020 Nov 10, 2020	SELL	$14.79 - $22.49 $18.6 Million - $28.3 Million	-1,256,887 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$20.64 - $30.69 $25.9 Million - $38.6 Million	1,256,887 New	1,256,887 $26.4 Million
Q2 2020 Aug 07, 2020	SELL	$20.64 - $30.69 $21.8 Million - $32.5 Million	-1,057,513 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$17.84 - $31.21 $18.9 Million - $33 Million	1,057,513 New	1,057,513 $24.4 Million
Q1 2020 May 08, 2020	SELL	$17.84 - $31.21 $19.2 Million - $33.6 Million	-1,075,589 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$16.12 - $25.89 $17.3 Million - $27.8 Million	1,075,589 New	1,075,589 $27.8 Million
Q4 2019 Feb 12, 2020	SELL	$16.12 - $25.89 $15.4 Million - $24.7 Million	-955,589 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$16.51 - $23.78 $15.8 Million - $22.7 Million	955,589 New	955,589 $18.6 Million
Q3 2019 Nov 08, 2019	SELL	$16.51 - $23.78 $15.3 Million - $22.1 Million	-928,256 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$15.6 - $25.15 $14.5 Million - $23.3 Million	928,256 New	928,256 $15.2 Million
Q2 2019 Aug 09, 2019	SELL	$15.6 - $25.15 $13.7 Million - $22 Million	-876,173 Closed	0 $0
Q4 2018 Mar 04, 2019	BUY	$22.52 - $35.07 $19.7 Million - $30.7 Million	876,173 New	876,173 $22.4 Million
Q4 2018 Feb 08, 2019	SELL	$22.52 - $35.07 $18.9 Million - $29.4 Million	-838,748 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$22.83 - $32.67 $19.1 Million - $27.4 Million	838,748 New	838,748 $27.4 Million
Q3 2018 Nov 09, 2018	SELL	$22.83 - $32.67 $18.3 Million - $26.1 Million	-799,533 Closed	0 $0
Q2 2018 Aug 12, 2019	BUY	$22.06 - $25.52 $17.6 Million - $20.4 Million	799,533 New	799,533 $18.1 Million
Q2 2018 Jul 23, 2018	SELL	$22.06 - $25.52 $15.8 Million - $18.3 Million	-717,753 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$23.37 - $29.71 $16.8 Million - $21.3 Million	717,753 New	717,753 $17.4 Million
Q1 2018 May 09, 2018	SELL	$23.37 - $29.71 $18.1 Million - $23 Million	-774,797 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$25.82 - $35.66 $20 Million - $27.6 Million	774,797 New	774,797 $21.6 Million
Q4 2017 Feb 09, 2018	SELL	$25.82 - $35.66 $20.7 Million - $28.6 Million	-803,327 Closed	0 $0
Q3 2017 Nov 13, 2018	BUY	$23.88 - $34.96 $19.2 Million - $28.1 Million	803,327 New	803,327 $27.5 Million
Q3 2017 Nov 07, 2017	SELL	$23.88 - $34.96 $19.2 Million - $28.1 Million	-803,327 Closed	0 $0
Q1 2017 May 11, 2018	SELL	N/A	-63,397 Reduced 7.31%	803,327 $29.6 Million
Q3 2016 Nov 13, 2017	BUY	N/A	866,724	866,724 $0

Others Institutions Holding TBPH

# of Institutions

122

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

Madison Avenue Partners, LP New York, NY

9.51M
Shares

$91.2 Million
9.44% of portfolio
Weiss Asset Management LP Boston, MA

7.46M
Shares

$71.5 Million
1.94% of portfolio
Newtyn Management, LLC New York, NY

4.5M
Shares

$43.1 Million
6.4% of portfolio
Black Rock Inc. New York, NY

3.78M
Shares

$36.3 Million
0.0% of portfolio
Irenic Capital Management LP New York, NY

2.76M
Shares

$26.5 Million
1.95% of portfolio

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account